2022
DOI: 10.4187/respcare.09446
|View full text |Cite
|
Sign up to set email alerts
|

Multidisciplinary Care and Prognosis in Patients With COPD and Interstitial Lung Disease Prescribed Long-Term Oxygen Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 29 publications
0
2
0
Order By: Relevance
“…Despite being recognised as a necessity by patients, caregivers and HCPs, end-of-life care is not readily available to patients with PF. According to HARRISON et al [61], only one-third of patients are referred to palliative care when they initiate long-term oxygen therapy, even though the mean survival time at this stage is only 1.5 years. The barriers referral include a perceived lack of local access to palliative care, lack of established optimal timing for referral, insufficiently specialised professionals, insufficient knowledge of the specific palliative care needs of patients with PF, and a lack of collaboration between palliative care and respiratory teams, as well as difficulties travelling, transportation difficulties, severe breathlessness and high supplemental oxygen requirements among patients [13,62].…”
Section: End-of-life Carementioning
confidence: 99%
“…Despite being recognised as a necessity by patients, caregivers and HCPs, end-of-life care is not readily available to patients with PF. According to HARRISON et al [61], only one-third of patients are referred to palliative care when they initiate long-term oxygen therapy, even though the mean survival time at this stage is only 1.5 years. The barriers referral include a perceived lack of local access to palliative care, lack of established optimal timing for referral, insufficiently specialised professionals, insufficient knowledge of the specific palliative care needs of patients with PF, and a lack of collaboration between palliative care and respiratory teams, as well as difficulties travelling, transportation difficulties, severe breathlessness and high supplemental oxygen requirements among patients [13,62].…”
Section: End-of-life Carementioning
confidence: 99%
“…[1][2][3] Despite recent advances in the treatment of ILDs, the symptom burden remains high, and for most patients disease progression is at best slowed down. [4][5][6][7] Supportive care in the forms of psychosocial support, oxygen therapy, pulmonary rehabilitation (PR), and palliative care are recommended, but they remain underutilized due to a multitude of factors. These factors range from issues regarding access to incomplete understanding of potential benefits.…”
Section: Introductionmentioning
confidence: 99%